Author:
Buchynska L.G., ,Glushchenko N.M.,Nespryadko S.V.,Marchenko I.O.,Iurchenko N.P., , , ,
Abstract
Summary. Aim: to evaluate the features of the expression of the cytokine TGF-β1 and the transcription factor Snail1 in endometrial tumor cells, depending on the degree of differentiation and the level of spread of the malignant process. Object and methods: surgical material samples of 54 patients with endometrioid carcinoma of the endometrium (ECE) with the I–II stage of the disease (median age 59 years), which were examined using: morphological, immunohistochemical and statistical methods. Results: significantly higher expression of cytokine TGF-β1 and transcription factor Snail1 was shown in low-differentiated endometrial carcinomas that invade deeply into the myometrium, compared to tumors of a high and moderate degree of differentiation with shallow invasion into the myometrium. In endometrial tumors with high Snail1 expression, a significant decrease in the expression of the epithelial cell marker E-cadherin and an increase in the expression of the mesenchymal marker vimentin were found. It was established that high mRNA expression of the TGFB1 and SNAI1 genes correlates with a decrease in the 5-year survival time of patients with ECE (GEPIA2 database). Conclusions: the results of the study suggest that, associated with the epithelial-mesenchymal transition, TGF-β1 and Snail1 modulate certain morphofunctional characteristics of malignant endometrial neoplasms and participate in the formation of the aggressiveness of this form of cancer. The obtained data indicate a high probability of using Snail1 and TGF-β1 as prognostic markers of the course of the disease in patients with this oncological pathology.
Publisher
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference27 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics 2021. CA. Cancer J Clin 2021; 71: 7-33. doi: 10.3322/caac.21654.
2. Fedorenko Z, Gulak L, Gorokh Ye, Ryzhov A, Soumkina O. Cancer in Ukraine, 2021-2022. Incidence, mortality, prevalence and other relevant statistics. Bul Nat Registry of Ukraine 2023; 24: 82 p. Available from: http://www.ncru.inf.ua
3. Corr B, Cosgrove C, Spinosa D,Guntupalli S. Endometrial cancer: molecular classification and future treatments. BMJMED 2022; 1:e000152. doi:10.1136/bmjmed-2022-000152.
4. Movchan OM, Svintsitskiy VS, Tsip NP, et al. Features of recurrence of endometrioid type endometrial cancer of I stage. Exp Oncol 2021; 43 (4): 365-69. doi: 10.32471/exp-oncology.2312-8852.vol-43-no 4.17052.
5. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma;Concin;Int J Gynecol Cancer,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献